Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review
Abstract
Reviany V. Nidom, Arif N. M. Ansori, Setyarina Indrasari, Irine Normalina, Muhammad K. J. Kusala, Asep Saefuddin, Chairul A. Nidom.
SARS-CoV-2 firstly emerged in China and sporadically transmitted worldwide. In March 2020, WHO announced that the infection was a pandemic. The outbreak and rapid transmission of COVID-19 have endangered the global health and the economy. This crisis has called for an extensive scientific mobilization of studies on SARS-CoV-2 concerning its clinical aspects, characteristics, and its mechanism of transmission. Although many scientists have published the treatment options against COVID-19, currently, there is not any approved medications against the virus yet. COVID-19 vaccine development has started in many research centers and pharmaceutical industries following the announcement of the agent and the full genome of SARS-CoV-2 recognized. Recently, the collected data described that COVID-19 vaccine candidates grouped into the following types: protein-based, epitope, inactivated or live-attenuated virus, virus-like particle, nucleic acid-based, and viral vectors. Therefore, the present review gives a sneak peek of recent updates on COVID-19 vaccine construction worldwide and COVID-19 vaccine’s acceptance in Indonesia.
How to Cite this Article |
Pubmed Style Nidom RV, Ansori ANM, Indrasari S, Normalina I, Kusala MKJ, Saefuddin A, Nidom CA. Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. SRP. 2020; 11(10): 807-818. doi:10.31838/srp.2020.10.121 Web Style Nidom RV, Ansori ANM, Indrasari S, Normalina I, Kusala MKJ, Saefuddin A, Nidom CA. Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. http://www.sysrevpharm.org/?mno=14123 [Access: March 29, 2021]. doi:10.31838/srp.2020.10.121 AMA (American Medical Association) Style Nidom RV, Ansori ANM, Indrasari S, Normalina I, Kusala MKJ, Saefuddin A, Nidom CA. Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. SRP. 2020; 11(10): 807-818. doi:10.31838/srp.2020.10.121 Vancouver/ICMJE Style Nidom RV, Ansori ANM, Indrasari S, Normalina I, Kusala MKJ, Saefuddin A, Nidom CA. Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. SRP. (2020), [cited March 29, 2021]; 11(10): 807-818. doi:10.31838/srp.2020.10.121 Harvard Style Nidom, R. V., Ansori, . A. N. M., Indrasari, . S., Normalina, . I., Kusala, . M. K. J., Saefuddin, . A. & Nidom, . C. A. (2020) Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. SRP, 11 (10), 807-818. doi:10.31838/srp.2020.10.121 Turabian Style Nidom, Reviany V., Arif N. M. Ansori, Setyarina Indrasari, Irine Normalina, Muhammad K. J. Kusala, Asep Saefuddin, and Chairul A. Nidom. 2020. Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. Systematic Reviews in Pharmacy, 11 (10), 807-818. doi:10.31838/srp.2020.10.121 Chicago Style Nidom, Reviany V., Arif N. M. Ansori, Setyarina Indrasari, Irine Normalina, Muhammad K. J. Kusala, Asep Saefuddin, and Chairul A. Nidom. "Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review." Systematic Reviews in Pharmacy 11 (2020), 807-818. doi:10.31838/srp.2020.10.121 MLA (The Modern Language Association) Style Nidom, Reviany V., Arif N. M. Ansori, Setyarina Indrasari, Irine Normalina, Muhammad K. J. Kusala, Asep Saefuddin, and Chairul A. Nidom. "Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review." Systematic Reviews in Pharmacy 11.10 (2020), 807-818. Print. doi:10.31838/srp.2020.10.121 APA (American Psychological Association) Style Nidom, R. V., Ansori, . A. N. M., Indrasari, . S., Normalina, . I., Kusala, . M. K. J., Saefuddin, . A. & Nidom, . C. A. (2020) Recent Updates on COVID-19 Vaccine Platforms and Its Immunological Aspects: A Review. Systematic Reviews in Pharmacy, 11 (10), 807-818. doi:10.31838/srp.2020.10.121 |